Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: A substudy from the BENEFIT trial
Quantitative real-time PCR (qPCR) is an accurate method to quantify Trypanosoma cruzi DNA and can be used to follow-up parasitemia in Chagas disease (CD) patients undergoing chemotherapy. The Benznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) study is an international, multicenter, r...
Autores Principales: | Moreira, Otalicio C., Ramírez, Juan David, Velázquez, Elsa, Días Melo, Myllena F. A., Lima Ferreira, Carolina, Gushi, Felipe, Sosa Estani, Sergio, Marín Neto, José Antonio, Morillo, Carlos A., Britto, Constanza |
---|---|
Formato: | Artículo (Article) |
Lenguaje: | Inglés (English) |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/26414 https://doi.org/10.1016/j.actatropica.2012.08.020 |
Ejemplares similares
-
First Colombian consensus on congenital Chagas and clinical approach to women of fertile age diagnosed with Chagas
por: Cucunubá, Zulma M., et al.
Publicado: (2017) -
High-resolution molecular typing of trypanosoma cruzi in 2 large outbreaks of acute chagas disease in Colombia
por: Galindo-Hernández, Carolina, et al.
Publicado: (2016) -
A systematic review of the Trypanosoma cruzi genetic heterogeneity, host immune response and genetic factors as plausible drivers of chronic chagasic cardiomyopathy
por: Jiménez P., et al.
Publicado: (2019) -
Multilocus PCR-RFLP profiling in Trypanosoma cruzi I highlights an intraspecific genetic variation pattern
por: Ramírez, Juan David, et al.
Publicado: (2012) -
Cytokine profiling in chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a benefit trial sub-study)
por: Poveda, Cristina, et al.
Publicado: (2014)